JP2010512343A - 置換アリルアミン類の調製および実用性 - Google Patents

置換アリルアミン類の調製および実用性 Download PDF

Info

Publication number
JP2010512343A
JP2010512343A JP2009540513A JP2009540513A JP2010512343A JP 2010512343 A JP2010512343 A JP 2010512343A JP 2009540513 A JP2009540513 A JP 2009540513A JP 2009540513 A JP2009540513 A JP 2009540513A JP 2010512343 A JP2010512343 A JP 2010512343A
Authority
JP
Japan
Prior art keywords
compound
agents
pharmaceutical composition
inhibitors
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009540513A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512343A5 (enExample
Inventor
トーマス・ジー・ガント
セパー・サーシャー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auspex Pharmaceuticals Inc
Original Assignee
Auspex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auspex Pharmaceuticals Inc filed Critical Auspex Pharmaceuticals Inc
Publication of JP2010512343A publication Critical patent/JP2010512343A/ja
Publication of JP2010512343A5 publication Critical patent/JP2010512343A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2009540513A 2006-12-08 2007-12-10 置換アリルアミン類の調製および実用性 Withdrawn JP2010512343A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86930906P 2006-12-08 2006-12-08
PCT/US2007/086917 WO2008073863A2 (en) 2006-12-08 2007-12-10 Preparation and utility of substituted allylamines

Publications (2)

Publication Number Publication Date
JP2010512343A true JP2010512343A (ja) 2010-04-22
JP2010512343A5 JP2010512343A5 (enExample) 2010-06-03

Family

ID=39402913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540513A Withdrawn JP2010512343A (ja) 2006-12-08 2007-12-10 置換アリルアミン類の調製および実用性

Country Status (4)

Country Link
US (1) US20080167312A1 (enExample)
EP (1) EP2121572A2 (enExample)
JP (1) JP2010512343A (enExample)
WO (1) WO2008073863A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012502038A (ja) * 2008-09-03 2012-01-26 テバ ファーマシューティカル インダストリーズ リミティド 免疫機能の２−オキソ−１，２−ジヒドロ−キノリンモジュレーター

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926813B1 (fr) * 2008-01-28 2011-10-21 Inst Francais Du Petrole Procede de separation du propane et du propylene mettant en oeuvre une colonne a distiller et une unite de separation par membrane
US9061060B2 (en) 2008-07-15 2015-06-23 Theracos Inc. Deuterated benzylbenzene derivatives and methods of use
US20120301463A1 (en) 2009-09-30 2012-11-29 President And Fellows Of Harvard College Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
CN106414392B (zh) * 2014-06-10 2019-05-14 华东理工大学 6,7,8,9-四氢-5h-苯并[7]轮烯-2-烷基胺类化合物及其用途
CN105016966A (zh) * 2015-07-31 2015-11-04 江苏恒润制药有限公司 一种（e）-1-氯-6,6-二甲基-2-庚烯-4-炔的制备方法
CN111514860B (zh) * 2020-05-09 2022-12-30 江南大学 一种羊毛废弃物的高效综合回收再利用方法
CN114380696B (zh) * 2021-12-23 2022-11-25 山东诚汇双达药业有限公司 一种盐酸特比萘芬的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1410A (en) * 1979-08-22 1988-04-22 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4870095A (en) * 1988-06-13 1989-09-26 Sterling Drug, Inc. 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
GB9509631D0 (en) * 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
US6440710B1 (en) * 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
EP1104760B1 (en) * 1999-12-03 2003-03-12 Pfizer Products Inc. Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
EP1134290A3 (en) * 2000-03-14 2004-01-02 Pfizer Products Inc. Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors
DE10162121A1 (de) * 2001-12-12 2003-06-18 Berolina Drug Dev Ab Svedala Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
TW200413273A (en) * 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
US20080033011A1 (en) * 2005-07-29 2008-02-07 Concert Pharmaceuticals Inc. Novel benzo[d][1,3]-dioxol derivatives
US7514068B2 (en) * 2005-09-14 2009-04-07 Concert Pharmaceuticals Inc. Biphenyl-pyrazolecarboxamide compounds
US7750168B2 (en) * 2006-02-10 2010-07-06 Sigma-Aldrich Co. Stabilized deuteroborane-tetrahydrofuran complex
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012502038A (ja) * 2008-09-03 2012-01-26 テバ ファーマシューティカル インダストリーズ リミティド 免疫機能の２−オキソ−１，２−ジヒドロ−キノリンモジュレーター
JP2015007060A (ja) * 2008-09-03 2015-01-15 テバ ファーマシューティカル インダストリーズ リミティド 免疫機能の２−オキソ−１，２−ジヒドロ−キノリンモジュレーター

Also Published As

Publication number Publication date
US20080167312A1 (en) 2008-07-10
WO2008073863A2 (en) 2008-06-19
EP2121572A2 (en) 2009-11-25
WO2008073863A3 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
JP5587184B2 (ja) 繊維症阻害剤としての置換ｎ−アリールピリジノン
US20080280886A1 (en) Substituted ureas
US20090291958A1 (en) Substituted PDE5 inhibitors
JP2010525081A (ja) 重水素標識ケタミン
US20090022706A1 (en) Substituted cyclohexenes
US20080132555A1 (en) Preparation and utility of substituted phenyltetrazoles
JP2010501011A (ja) オピオイド鎮痛薬の調製および効用
JP2009539866A (ja) 置換エリスロマイシンアナログの調製および有用性
US20080146573A1 (en) Preparation and utility of substituted oxzolidinones
JP2010512343A (ja) 置換アリルアミン類の調製および実用性
CN105979946A (zh) 取代的n-芳基吡啶酮
AU2015261706B2 (en) Substituted n-aryl pyridinones

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100311

A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20110301